Oncogenic and tumor-suppressive microRNAs in prostate cancer
Author:
Funder
Urology Care Foundation
U.S. Department of Defense
Publisher
Elsevier BV
Subject
Endocrinology, Diabetes and Metabolism
Reference75 articles.
1. Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches;Karantanos;Oncogene,2013
2. The role of miRNAs as biomarkers in prostate cancer;Cozar;Mutat Res Rev Mutat Res,2019
3. Updates to the experimentally validated microRNA-target interaction database;Huang;Nucleic Acids Res,2020
4. Epithelial mesenchymal transition and resistance in endocrine-related cancers;Culig;Biochim Biophys Acta Mol Cell Res,2019
5. MiR-543 promotes proliferation and epithelial-mesenchymal transition in prostate cancer via targeting RKIP;Du;Cell Physiol Biochem,2017
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Dysregulated expression of miR‑367 in disease development and its prospects as a therapeutic target and diagnostic biomarker (Review);Biomedical Reports;2023-10-10
2. Integrative analysis of the SOX family-related prognostic signature and immunological infiltration in prostate cancer;Translational Cancer Research;2023-08
3. The role of miRNA in prostate cancer diagnosis, prognosis and treatment response: a narrative review;Future Oncology;2023-01
4. A decade's worth of impact: Dox loaded liposomes in anticancer activity;Materials Today Advances;2022-12
5. From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer;International Journal of Molecular Sciences;2022-06-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3